CNPCX
Price
$65.34
Change
-$0.19 (-0.29%)
Updated
Aug 11 closing price
Net Assets
157.43B
RPEBX
Price
$68.52
Change
-$0.19 (-0.28%)
Updated
Aug 11 closing price
Net Assets
157.43B
Interact to see
Advertisement

CNPCX vs RPEBX

Header iconCNPCX vs RPEBX Comparison
Open Charts CNPCX vs RPEBXBanner chart's image
American Funds New Perspective 529C
Price$65.34
Change-$0.19 (-0.29%)
VolumeN/A
Net Assets157.43B
American Funds New Perspective R2E
Price$68.52
Change-$0.19 (-0.28%)
VolumeN/A
Net Assets157.43B
CNPCX vs RPEBX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
CNPCX vs. RPEBX commentary
Aug 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNPCX is a Buy and RPEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CNPCX (157B) and RPEBX (157B) have equal amount of cash in the bank . RPEBX pays higher dividends than CNPCX: RPEBX (0.12) vs CNPCX (0.00). CNPCX was incepted earlier than RPEBX: CNPCX (24 years) vs RPEBX (11 years). CNPCX (1.52) is less costly to investors than RPEBX (1.21). CNPCX (24.00) and RPEBX (24.00) have comparable annual turnover. CNPCX (250) and RPEBX (250) have matching initial minimum investment requirements. RPEBX (15.32) and CNPCX (14.71) have marching annual gain over last year. RPEBX return over 5 years is better than : 33.41 vs. CNPCX (30.48).
CNPCXRPEBXCNPCX / RPEBX
Total Expense Ratio1.521.21126%
Annual Report Gross Expense Ratio1.521.21126%
Fund Existence24 years11 years-
Gain YTD13.28013.50098%
Front LoadN/AN/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets157B157B100%
Annual Yield % from dividends0.000.12-
Returns for 1 year14.7115.3296%
Returns for 3 years29.6231.1895%
Returns for 5 years30.4833.4191%
Returns for 10 years75.7778.6196%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ARTL10.031.68
+20.12%
Artelo Biosciences Inc
GEN30.770.32
+1.05%
Gen Digital
INTR7.76-0.02
-0.26%
Inter & Co
TBPH11.40-0.11
-1.00%
Theravance Biopharma
GSIW0.12N/A
-3.76%
Garden Stage Limited